Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of AstraZeneca's AZD-4604?
AZD-4604 is a small molecule commercialized by AstraZeneca, with a leading Phase II program in Asthma. According to Globaldata, it...
Data Insights
Risk adjusted net present value: What is the current valuation of AstraZeneca's AZD-4604?
AZD-4604 is a small molecule commercialized by AstraZeneca, with a leading Phase II program in Asthma. According to Globaldata, it...